Product NDC: | 41163-160 |
Proprietary Name: | Senna S |
Non Proprietary Name: | DOCUSATE SODIUM, SENNOSIDES |
Active Ingredient(s): | 50; 8.6 mg/1; mg/1 & nbsp; DOCUSATE SODIUM, SENNOSIDES |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 41163-160 |
Labeler Name: | EQUALINE (SuperValu) |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part334 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20130315 |
Package NDC: | 41163-160-30 |
Package Description: | 1 BOTTLE in 1 BOX (41163-160-30) > 30 TABLET in 1 BOTTLE |
NDC Code | 41163-160-30 |
Proprietary Name | Senna S |
Package Description | 1 BOTTLE in 1 BOX (41163-160-30) > 30 TABLET in 1 BOTTLE |
Product NDC | 41163-160 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | DOCUSATE SODIUM, SENNOSIDES |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130315 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | EQUALINE (SuperValu) |
Substance Name | DOCUSATE SODIUM; SENNOSIDES |
Strength Number | 50; 8.6 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |